Sichuan Kelun-Biotech Subscribes to 250 Million Yuan Structured Deposits of Bank of Chengdu

MT Newswires Live07-25

Sichuan Kelun-Biotech Biopharmaceutical (HKG:6990) agreed to subscribe to Bank of Chengdu's structured deposit under two subscription agreements, with a total principal amount of 250.0 million yuan, a Wednesday filing with the Hong Kong Exchange said.

On July 9, the company subscribed for the bank's principal-guaranteed with floating return type "Fu Rong Jin Cheng" unit structured deposit with a principal amount of 50.0 million yuan. The deposit has an expected annualized floating rate of return between 1.54% to 2.70% and it matures on Oct. 11, 2024.

The company, on July 24, subscribed for the bank's principal-guaranteed with floating return type "Fu Rong Jin Cheng" unit structured deposit with a principal amount of 200.0 million yuan. The deposit has an expected annualized floating rate of return between 1.54% to 2.70% and it matures on Nov. 26, 2024.

The company's shares were down over 1% in recent trade.

Price (HKD): $148.60, Change: $-2.10, Percent Change: -1.39%

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment